172 related articles for article (PubMed ID: 24192271)
1. Inhibition of the classical and lectin pathway of the complement system by recombinant LAIR-2.
Olde Nordkamp MJ; Boross P; Yildiz C; Jansen JH; Leusen JH; Wouters D; Urbanus RT; Hack CE; Meyaard L
J Innate Immun; 2014; 6(3):284-92. PubMed ID: 24192271
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of Complement C1q Collagen-Like Region Interaction with the Immunoglobulin-Like Receptor LAIR-1.
Fouët G; Bally I; Chouquet A; Reiser JB; Thielens NM; Gaboriaud C; Rossi V
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066122
[TBL] [Abstract][Full Text] [Related]
3. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression.
Son M; Diamond B; Volpe BT; Aranow CB; Mackay MC; Santiago-Schwarz F
Sci Rep; 2017 Mar; 7(1):270. PubMed ID: 28325905
[TBL] [Abstract][Full Text] [Related]
4. Complement-fixing donor-specific anti-HLA antibodies and kidney allograft failure.
Cazarote HB; Shimakura S; Valdameri JS; Contieri FLC; von Glehn CQC; Aita CM; Susin MF; Sotomaior VS; Glehn-Ponsirenas R
Transpl Immunol; 2018 Aug; 49():33-38. PubMed ID: 29596992
[TBL] [Abstract][Full Text] [Related]
5. Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation.
Ramon DS; Huang Y; Zhao L; Rendulic T; Park JM; Sung RS; Samaniego M
Hum Immunol; 2017 Feb; 78(2):57-63. PubMed ID: 27894836
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction.
Ramos MIP; Tian L; de Ruiter EJ; Song C; Paucarmayta A; Singh A; Elshof E; Vijver SV; Shaik J; Bosiacki J; Cusumano Z; Jensen C; Willumsen N; Karsdal MA; Liu L; Langermann S; Willems S; Flies D; Meyaard L
Elife; 2021 Jun; 10():. PubMed ID: 34121658
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.
Vo AA; Zeevi A; Choi J; Cisneros K; Toyoda M; Kahwaji J; Peng A; Villicana R; Puliyanda D; Reinsmoen N; Haas M; Jordan SC
Transplantation; 2015 Feb; 99(2):299-308. PubMed ID: 25606785
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
[TBL] [Abstract][Full Text] [Related]
9. C1q limits dendritic cell differentiation and activation by engaging LAIR-1.
Son M; Santiago-Schwarz F; Al-Abed Y; Diamond B
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):E3160-7. PubMed ID: 23093673
[TBL] [Abstract][Full Text] [Related]
10. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
[TBL] [Abstract][Full Text] [Related]
11. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
Skliris A; Happonen KE; Terpos E; Labropoulou V; Børset M; Heinegård D; Blom AM; Theocharis AD
Eur J Immunol; 2011 Feb; 41(2):437-49. PubMed ID: 21268013
[TBL] [Abstract][Full Text] [Related]
12. Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1.
Vijver SV; Singh A; Mommers-Elshof ETAM; Meeldijk J; Copeland R; Boon L; Langermann S; Flies D; Meyaard L; Ramos MIP
Front Immunol; 2021; 12():733561. PubMed ID: 34691040
[TBL] [Abstract][Full Text] [Related]
13. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
[TBL] [Abstract][Full Text] [Related]
14. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
[TBL] [Abstract][Full Text] [Related]
15. C1q-mediated repression of human monocytes is regulated by leukocyte-associated Ig-like receptor 1 (LAIR-1).
Son M; Diamond B
Mol Med; 2015 Feb; 20(1):559-68. PubMed ID: 25247291
[TBL] [Abstract][Full Text] [Related]
16. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
Yell M; Muth BL; Kaufman DB; Djamali A; Ellis TM
Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705
[TBL] [Abstract][Full Text] [Related]
17. Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III.
Lebbink RJ; Raynal N; de Ruiter T; Bihan DG; Farndale RW; Meyaard L
Matrix Biol; 2009 May; 28(4):202-10. PubMed ID: 19345263
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of the classical complement pathway by C1q-binding peptides.
Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR
J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D.
Olde Nordkamp MJ; van Eijk M; Urbanus RT; Bont L; Haagsman HP; Meyaard L
J Leukoc Biol; 2014 Jul; 96(1):105-11. PubMed ID: 24585933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
